Down-Regulation of Surface CD28 Under Belatacept Treatment: An Escape Mechanism for Antigen-Reactive T-Cells

PLoS ONE - United States
doi 10.1371/journal.pone.0148604
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Mechanism for Down-Regulation of CD28 by Nef

EMBO Journal
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2001English

Restoration of CD28 Expression in CD28−CD8+Memory Effector T Cells Reconstitutes Antigen-Induced IL-2 Production

Journal of Experimental Medicine
MedicineAllergyImmunology
2003English

High-Throughput Screening of Human Tumor-Antigen Specific CD4 T Cells, Including Neo-Antigen Reactive T Cells

Clinical Cancer Research
Cancer ResearchOncology
2019English

CD28 Costimulation Independence of Target Organ Versus Circulating Memory Antigen-Specific CD4+ T Cells

Journal of Clinical Investigation
Medicine
2003English

Chimeric Antigen Receptor T Cells for the Treatment of Lymphoma

Annals of Lymphoma
2017English

Tandem CAR T Cells Targeting HER2 and IL13Rα2 Mitigate Tumor Antigen Escape

Journal of Clinical Investigation
Medicine
2016English

Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody–Activated Chimeric Antigen Receptor–Modified T Cells

Journal of Immunology
AllergyImmunology
2017English

CD28 Co-Stimulation Induced LCK Signaling Is Important for Survival and Antigen-Specific Functionality of Re-Directed T Cells

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2013English

CD28 and HIV-1 Infection of T Cells

Science
MultidisciplinaryPhilosophy of ScienceHistory
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy